Revenue and Profit - The company's revenue for Q1 2023 was ¥178,181,357.03, representing a 0.98% increase compared to ¥176,460,166.04 in the same period last year[5]. - Net profit attributable to shareholders increased by 26.16% to ¥26,200,020.77 from ¥20,768,036.98 year-on-year[5]. - The net profit for Q1 2023 was CNY 26,967,530.94, an increase of 28.5% compared to CNY 21,055,813.65 in Q1 2022[18]. - The total comprehensive income for the quarter was CNY 26,967,530.94, up from CNY 21,055,813.65, reflecting a growth of 28.5%[18]. - The operating profit for the quarter was CNY 32,523,397.31, slightly up from CNY 32,250,776.39 in the same period last year[18]. - The total revenue from sales of goods and services was CNY 213,424,892.28, down from CNY 266,859,837.30 in the same quarter last year[19]. Earnings Per Share - The basic earnings per share increased by 40.00% to ¥0.07 from ¥0.05 in the same period last year[5]. - The diluted earnings per share rose by 75.00% to ¥0.07 compared to ¥0.04 in the previous year[5]. - Basic earnings per share increased to CNY 0.07 from CNY 0.05, representing a 40% growth year-over-year[19]. Cash Flow - The net cash flow from operating activities rose by 50.60% to ¥81,269,322.47, up from ¥53,963,803.57 in the previous year[5]. - Cash flow from operating activities generated a net amount of CNY 81,269,322.47, compared to CNY 53,963,803.57 in the previous year, marking a 50.5% increase[19]. - The company reported a net cash outflow from investing activities of CNY -107,441,702.06, compared to CNY -178,635,733.07 in the previous year[20]. - The net cash flow from financing activities was CNY -22,125,866.66, a decrease from CNY 26,837,165.30 in Q1 2022[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥3,075,299,908.89, a 2.46% increase from ¥3,001,505,600.79 at the end of the previous year[5]. - Current liabilities totaled ¥974,072,980.92, an increase from ¥928,383,132.13, reflecting a growth of approximately 4.9%[15]. - The company's total equity attributable to shareholders increased by 1.62% to ¥1,693,383,701.79 from ¥1,666,414,408.61 at the end of the previous year[5]. - The total equity attributable to shareholders reached ¥1,693,383,701.79, compared to ¥1,666,414,408.61 at the start of the year, showing an increase of about 1.6%[15]. Research and Development - R&D expenses for the period amounted to ¥4,320,600, reflecting a 62.19% increase compared to the previous period[8]. - Research and development expenses rose significantly to ¥4,320,611.37, compared to ¥2,663,889.24 in the previous period, indicating an increase of approximately 62.0%[17]. Other Financial Metrics - The company reported a significant decrease of 62.79% in the balance of receivables financing, attributed to an increase in payment settlements during the reporting period[8]. - The company experienced a 396.71% increase in other current liabilities, primarily due to an increase in advance payments received[8]. - The company's cash and cash equivalents decreased to ¥268,939,124.03 from ¥317,242,553.40, a decline of approximately 15.2%[13]. - Inventory levels increased to ¥57,699,208.58 from ¥55,122,953.15, representing a growth of about 4.7%[13]. - The long-term equity investments slightly increased to ¥125,588,060.79 from ¥125,426,641.87, indicating a marginal growth of approximately 0.1%[13]. - The company reported a net investment loss of ¥151,913.50, a significant improvement compared to a loss of ¥10,260,642.33 in the previous period[17]. - The company incurred income tax expenses of CNY 6,398,751.15, a decrease from CNY 11,821,139.63 in Q1 2022[18].
同德化工(002360) - 2023 Q1 - 季度财报